Divergence Entropy-Based Evaluation of Hydrophobic Core in Aggressive and Resistant Forms of Transthyretin

The two forms of transthyretin differing slightly in the tertiary structure, despite the presence of five mutations, show radically different properties in terms of susceptibility to the amyloid transformation process. These two forms of transthyretin are the object of analysis. The search for the sources of these differences was carried out by means of a comparative analysis of the structure of these molecules in their native and early intermediate stage forms in the folding process. The criterion for assessing the degree of similarity and differences is the status of the hydrophobic core. The comparison of the level of arrangement of the hydrophobic core and its initial stages is possible thanks to the application of divergence entropy for the early intermediate stage and for the final forms. It was shown that the minimal differences observed in the structure of the hydrophobic core of the forms available in PDB, turned out to be significantly different in the early stage (ES) structure in folding process. The determined values of divergence entropy for both ES forms indicate the presence of the seed of hydrophobic core only in the form resistant to amyloid transformation. In the form of aggressively undergoing amyloid transformation, the structure lacking such a seed is revealed, being a stretched one with a high content of β-type structure. In the discussed case, the active presence of water in the structural transformation of proteins expressed in the fuzzy oil drop model (FOD) is of decisive importance for the generation of the final protein structure. It has been shown that the resistant form tends to generate a centric hydrophobic core with the possibility of creating a globular structure, i.e., a spherical micelle-like form. The aggressively transforming form reveals in the structure of its early intermediate, a tendency to form the ribbon-like micelle as observed in amyloid.

[1]  G. Chiellini,et al.  Transthyretin Stabilization: An Emerging Strategy for the Treatment of Alzheimer’s Disease? , 2020, International journal of molecular sciences.

[2]  V. Daggett,et al.  Edge strand dissociation and conformational changes in transthyretin under amyloidogenic conditions. , 2020, Biophysical journal.

[3]  I. Roterman,et al.  The Structure of Amyloid Versus the Structure of Globular Proteins , 2020, International journal of molecular sciences.

[4]  Irena Roterman-Konieczna,et al.  The Status of Edge Strands in Ferredoxin-Like Fold , 2020, Symmetry.

[5]  I. Roterman,et al.  Model of Early Stage Intermediate in Respect to Its Final Structure , 2019, Biomolecules.

[6]  Mateusz Banach,et al.  The Amyloid as a Ribbon-Like Micelle in Contrast to Spherical Micelles Represented by Globular Proteins , 2019, Molecules.

[7]  V. Daggett,et al.  Drivers of α-sheet formation in transthyretin under amyloidogenic conditions. , 2019, Biochemistry.

[8]  I. Hung,et al.  Two distinct aggregation pathways in transthyretin misfolding and amyloid formation. , 2019, Biochimica et biophysica acta. Proteins and proteomics.

[9]  B. L. de Groot,et al.  A molecular mechanism for transthyretin amyloidogenesis , 2019, Nature Communications.

[10]  D. Eisenberg,et al.  Crystal structures of amyloidogenic segments of human transthyretin , 2018, Protein science : a publication of the Protein Society.

[11]  F. Fogolari,et al.  Dynamics and Thermodynamics of Transthyretin Association from Molecular Dynamics Simulations , 2018, BioMed research international.

[12]  J. Kelly,et al.  Pathogenic Mutations Induce Partial Structural Changes in the Native β-Sheet Structure of Transthyretin and Accelerate Aggregation. , 2017, Biochemistry.

[13]  David A. Lee,et al.  CATH: an expanded resource to predict protein function through structure and sequence , 2016, Nucleic Acids Res..

[14]  Duilio Cascio,et al.  Uncovering the Mechanism of Aggregation of Human Transthyretin , 2015, The Journal of Biological Chemistry.

[15]  Irena Roterman-Konieczna,et al.  Application of Divergence Entropy to Characterize the Structure of the Hydrophobic Core in DNA Interacting Proteins , 2015, Entropy.

[16]  M. Vieira,et al.  Transthyretin: a multifaceted protein , 2014, Biomolecular concepts.

[17]  A. Martinelli,et al.  Computational studies on transthyretin. , 2012, Current medicinal chemistry.

[18]  M. Saraiva,et al.  Transthyretin: roles in the nervous system beyond thyroxine and retinol transport , 2012, Expert review of endocrinology & metabolism.

[19]  Michele Vendruscolo,et al.  Experimental free energy surfaces reveal the mechanisms of maintenance of protein solubility , 2011, Proceedings of the National Academy of Sciences.

[20]  B. Volkman,et al.  Native-state interconversion of a metamorphic protein requires global unfolding. , 2011, Biochemistry.

[21]  M. Sousa,et al.  Aboard transthyretin: From transport to cleavage , 2010, IUBMB life.

[22]  Cândida G. Silva,et al.  Potentially amyloidogenic conformational intermediates populate the unfolding landscape of transthyretin: Insights from molecular dynamics simulations , 2010, Protein science : a publication of the Protein Society.

[23]  J. Buxbaum,et al.  Transthyretin: the servant of many masters , 2009, Cellular and Molecular Life Sciences.

[24]  Gianluca Pollastri,et al.  Structural alphabets for protein structure classification: a comparison study. , 2009, Journal of molecular biology.

[25]  E. Génin,et al.  On the Origin of the Transthyretin Val30Met Familial Amyloid Polyneuropathy , 2008, Annals of human genetics.

[26]  J. Kelly,et al.  Human-Murine Transthyretin Heterotetramers Are Kinetically Stable and Non-amyloidogenic , 2008, Journal of Biological Chemistry.

[27]  John D. Hunter,et al.  Matplotlib: A 2D Graphics Environment , 2007, Computing in Science & Engineering.

[28]  A. Esteras-Chopo,et al.  Early kinetics of amyloid fibril formation reveals conformational reorganisation of initial aggregates. , 2007, Journal of molecular biology.

[29]  Fabrizio Chiti,et al.  Sequence and structural determinants of amyloid fibril formation. , 2006, Accounts of chemical research.

[30]  C. Dobson,et al.  Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.

[31]  J. Kelly,et al.  Partitioning conformational intermediates between competing refolding and aggregation pathways: insights into transthyretin amyloid disease. , 2005, Biochemistry.

[32]  Mark D. Fox,et al.  The "slip". , 2005, The virtual mentor : VM.

[33]  M. Lei,et al.  Initial conformational changes of human transthyretin under partially denaturing conditions. , 2005, Biophysical journal.

[34]  U. W. Hultdin,et al.  The effect of iodide and chloride on transthyretin structure and stability. , 2005, Biochemistry.

[35]  J. Prausnitz,et al.  Amyloid fibril formation by peptide LYS (11-36) in aqueous trifluoroethanol. , 2004, Biomacromolecules.

[36]  Leszek Konieczny,et al.  Conformational subspace in simulation of early‐stage protein folding , 2004, Proteins.

[37]  S. Wijmenga,et al.  Probing Solvent Accessibility of Transthyretin Amyloid by Solution NMR Spectroscopy* , 2004, Journal of Biological Chemistry.

[38]  C. Dobson,et al.  Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme , 2002, Nature Structural Biology.

[39]  Joana Almeida Palha,et al.  Transthyretin as a Thyroid Hormone Carrier: Function Revisited , 2002, Clinical chemistry and laboratory medicine.

[40]  J. Hamilton,et al.  Transthyretin: a review from a structural perspective , 2001, Cellular and Molecular Life Sciences CMLS.

[41]  H. M. Petrassi,et al.  An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. , 2001, Biochemistry.

[42]  Rui M. M. Brito,et al.  Tetramer Dissociation and Monomer Partial Unfolding Precedes Protofibril Formation in Amyloidogenic Transthyretin Variants* , 2001, The Journal of Biological Chemistry.

[43]  D. Wemmer,et al.  A glimpse of a possible amyloidogenic intermediate of transthyretin , 2000, Nature Structural Biology.

[44]  C. Dobson,et al.  Protein subunit interactions and structural integrity of amyloidogenic transthyretins: evidence from electrospray mass spectrometry. , 1998, Journal of molecular biology.

[45]  I Roterman,et al.  Modelling the optimal simulation path in the peptide chain folding--studies based on geometry of alanine heptapeptide. , 1995, Journal of theoretical biology.

[46]  J. Kelly,et al.  Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. , 1992, Biochemistry.

[47]  M. Skinner,et al.  Cloning of human prealbumin complementary DNA. Localization of the gene to chromosome 18 and detection of a variant prealbumin allele in a family with familial amyloid polyneuropathy. , 1984, Molecular biology & medicine.

[48]  M. Levitt A simplified representation of protein conformations for rapid simulation of protein folding. , 1976, Journal of molecular biology.

[49]  C. Anfinsen Principles that govern the folding of protein chains. , 1973, Science.

[50]  R. A. Leibler,et al.  On Information and Sufficiency , 1951 .

[51]  Mateusz Banach,et al.  SUPPLEMENT A , 2020 .

[52]  I. Roterman,et al.  Information encoded in protein structure , 2020 .

[53]  I. Roterman,et al.  Anti-amyloid drug design , 2020, From Globular Proteins to Amyloids.

[54]  I. Roterman,et al.  Description of the fuzzy oil drop model , 2020, From Globular Proteins to Amyloids.

[55]  Irena Roterman-Konieczna,et al.  The early-stage intermediate , 2012 .

[56]  D. Small,et al.  Mechanisms of transthyretin aggregation and toxicity. , 2012, Sub-cellular biochemistry.

[57]  C. E. Fleming,et al.  Chapter 17: Transthyretin: an enhancer of nerve regeneration. , 2009, International review of neurobiology.

[58]  Irena Roterman-Konieczna,et al.  Gauss-Function-Based Model of Hydrophobicity Density in Proteins , 2006, Silico Biol..

[59]  D. Teplow,et al.  Kinetic studies of amyloid beta-protein fibril assembly. Differential effects of alpha-helix stabilization. , 2002, The Journal of biological chemistry.

[60]  Scott A. Peterson,et al.  Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid. , 1997, Advances in protein chemistry.

[61]  L. Serpell,et al.  The "edge strand" hypothesis: Prediction and test of a mutational "hot-spot" on the transthyretin molecule associated with FAP amyloidogenesis , 1996 .

[62]  I Roterman,et al.  The geometrical analysis of peptide backbone structure and its local deformations. , 1995, Biochimie.

[63]  H. Berman,et al.  The Protein Data Bank. , 2002, Acta crystallographica. Section D, Biological crystallography.